Sort   by:  
 Page size 
UnknownChanneling of New Neuropsychiatric Drugs-Impact on Safety and Effectiveness Studies.
Not available
S-EPMC10121961 | biostudies-literature
UnknownAPOBEC signature mutation generates an oncogenic enhancer that drives LMO1 expression in T-ALL.
Not available
S-EPMC5629363 | biostudies-literature
UnknownSmall genomic insertions form enhancers that misregulate oncogenes.
Not available
S-EPMC5309821 | biostudies-literature
UnknownMAPT H2 haplotype and risk of Pick's disease in the Pick's disease International Consortium: a genetic association study.
Not available
S-EPMC11877577 | biostudies-literature
UnknownGenome-wide association study of Alzheimer's disease with psychotic symptoms.
Not available
S-EPMC3272435 | biostudies-literature
UnknownEvaluating the Appropriate Use Criteria for Coronary Revascularization in Stable Ischemic Heart Disease Using Randomized Data From the ISCHEMIA Trial.
Not available
S-EPMC11919559 | biostudies-literature
UnknownDistinct Subgroups in Hypertrophic Cardiomyopathy in the NHLBI HCM Registry.
Not available
S-EPMC6905038 | biostudies-literature
UnknownCommon genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivity.
Not available
S-EPMC8240954 | biostudies-literature
UnknownFactors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial.
Not available
S-EPMC11187765 | biostudies-literature
UnknownInitial Invasive or Conservative Strategy for Stable Coronary Disease.
Not available
S-EPMC7263833 | biostudies-literature
Sort   by:  
 Page size